Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression

    The purpose of this study is to determine if a single 30-minute session of transcranial direct current stimulation, or tDCS, can help people with mild ...

    View Details

  • A Multi-Center study in Patients Undergoing Total Knee Replacement with Smith+Nephew Porous Total Knee Arthroplasty (TKA) Systems

    The purpose of this study is to assess the safety and effectiveness of the Porous Total Knee System. The total knee system is made up ...

    View Details

  • Exploring Associations Between Fatigue and Metabolic Syndrome in Black Women

    The purpose of this research study is to describe fatigue in Black women with Metabolic Syndrome. Metabolic Syndrome is a cluster of conditions that includes ...

    View Details

  • The Stop Flu NYU cohort study

    This study is being conducted to study the body’s response to the seasonal influenza vaccination and to learn about the protection from infection with ...

    View Details


    The main reason this research study is being done is to see if an additional COVID-19 vaccine (a booster) will help people with autoimmune disease ...

    View Details

  • Performance Evaluation of 3D DIXON MRI of Joints

    The purpose of this study is to develop a method for faster MRI of joints. This study will test whether this new technique is reliable ...

    View Details

  • MASALA Study Expansion

    The purpose of this research study is to understand the causes of heart disease and stroke in South Asians and compare these causes to those ...

    View Details

  • A Randomized Placebo-Controlled Double-Blind Phase 1 Study of ART24 in Subjects Recently Cured of a Clostridioides difficile Infection (CDI)

    The purpose of this study is to evaluate the safety and tolerability of ART24 after 28 days of daily administration for subjects who have already ...

    View Details